|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 6.960 USD | -4.53% |
|
-27.88% | -42.67% |
| 09-15 | Ocular Therapeutix, Inc. Completes Pre-NDA Meeting With FDA For AXPAXLI In Wet AMD | CI |
| 09-15 | Ocular Therapeutix Plans to File Eye Disease Drug Marketing Application in Q4 | MT |
| Market Cap | 1.53B 1.36B 1.27B 1.16B 2.18B 147B 2.2B 15.34B 5.94B 75.12B 5.74B 5.61B 241B | P/E 2026 * |
-4.67x | P/E 2027 * | -5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.15B 1.02B 954M 870M 1.64B 111B 1.66B 11.55B 4.47B 56.54B 4.32B 4.23B 181B | EV / Sales 2026 * |
21.7x | EV / Sales 2027 * | 14.3x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCUL | Delayed | |
CBOE
| OCUL | Real-time | |
|
Tradegate
| 0OT | Real-time | |
|
Börse Stuttgart
| 0OT | Delayed | |
|
Boerse Muenchen
| 0OT | Real-time | |
|
Deutsche Boerse AG
| 0OT | Delayed | |
|
Berne S.E.
| 0OT | End-of-day quote |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | -4.53% | ||
| 1 week | -27.88% | ||
| Current month | -9.26% | ||
| 1 month | -34.59% | ||
| 3 months | -27.80% | ||
| 6 months | -18.02% | ||
| Current year | -42.67% |
| 1 week | 6.94 |  | 8.16 |
| 1 month | 6.94 | | 11.48 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 2024-04-14 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 2026-01-19 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 2024-05-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 2019-06-30 |
| Director/Board Member | 78 | 2012-11-04 | |
Leslie Williams
BRD | Director/Board Member | 66 | 2019-03-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Sell | Chief Operating Officer | -1,099 | 0.0005% | ||
| 8/25/26 | Don | Chief Executive Officer | -100,184 | 0.0473% | ||
| 8/24/26 | Sell | Executive/Senior Manager | -3,035 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.53% | -27.88% | -39.00% | +152.17% | 1.53B | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +41.71% | 333B | |
| -1.46% | -2.89% | +10.57% | +32.81% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.98% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -1.14% | -5.98% | +19.56% | +68.00% | 369.87B | |
| Weighted average by Cap. | -0.60% | -3.55% | +29.04% | +70.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.93M 47.03M 43.89M 40.01M 75.45M 5.09B 76.15M 531M 206M 2.6B 199M 194M 8.35B | 102M 91.05M 84.98M 77.46M 146M 9.85B 147M 1.03B 399M 5.04B 385M 376M 16.16B |
| Net income | -334M -297M -277M -253M -477M -32.14B -481M -3.35B -1.3B -16.43B -1.26B -1.23B -52.73B | -324M -288M -269M -245M -462M -31.19B -467M -3.26B -1.26B -15.94B -1.22B -1.19B -51.17B |
| Net Debt | -378M -336M -313M -286M -539M -36.34B -544M -3.79B -1.47B -18.58B -1.42B -1.39B -59.62B | -66M -58.64M -54.73M -49.89M -94.08M -6.34B -94.96M -662M -257M -3.24B -248M -242M -10.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$6.960 | -4.53% | 4,958,197 |
| 26-10-01 | US$7.290 | -4.95% | 4,514,297 |
| 26-09-30 | US$7.670 | -2.54% | 4,568,574 |
| 26-09-29 | US$7.870 | +2.81% | 5,286,714 |
| 26-09-28 | US$7.655 | -20.67% | 15,442,389 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
